Oral Versus Intravenous Antibiotics in Septic Arthritis
Date First Published:
August 27, 2026
Last Updated:
August 27, 2026
Report by:
Christine Chalhoub MD, Sean Farley MD, Senior EM resident, EM faculty (Corewell Health/Michigan State University Emergency Medicine Residency Program)
Search checked by:
Jeffrey Jones MD, Research Director
Three-Part Question:
In [emergency department patients with septic arthritis] are [oral antibiotics] non-inferior to [intravenous antibiotics] in terms of [treatment success or complications]?
Clinical Scenario:
A 30-year-old patient presents to the emergency department with knee pain for 48 hours, fever, and decreased range of motion at the knee. She has a history of type II diabetes and no prior orthopedic surgeries. Reports left knee swelling, redness, feels warm to the touch, and denies traumatic injury. The patient is unable to bear weight on the extremity and range of motion is painful. Arthrocentesis demonstrates findings consistent with septic arthritis. You wonder if oral antibiotics are are as effective intravenous (IV) antibiotics for treatment.
Search Strategy:
Medline 1966-7/26 using PubMed, Cochrane Library (2026), and Embase
Search Details:
[("septic arthritis" OR "bone and joint infection") AND ("oral antibiotics" OR "oral therapy") AND ("intravenous antibiotics" OR IV) AND (randomized trial OR systematic review OR meta-analysis)]
Outcome:
12 papers were identified. Nine were excluded because they were duplicates, narrative reviews, or did not directly compare oral versus intravenous antibiotic therapy. Three high-quality systematic reviews/meta-analyses were included.
Relevant Paper(s):
| Study Title | Patient Group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
|---|---|---|---|---|---|
| Oral versus intravenous antibiotics for bone and joint infections: Systematic review and meta-analysis of randomized controlled trials. Lima JPC, Chagas KA, Oliveira LBP, Filho BSB, Vital FMR. July 2025 Brazil | 1,723 patients with bone and joint infections from 9 RCTs | Systematic review and meta-analysis | Treatment failure, recurrence, adverse events, hospitalization | PO and IV therapies showed comparable efficacy in treatment failure (RR 0.96) and adverse events (RR 1.00). Superinfection rates showed no difference (RR 1.12). Although not statistically significant, hospitalization duration may be shorter with PO therapy | Included heterogeneous infections, subgroup suggested slightly higher recurrence in fracture-rated populations, |
| Oral antibiotics demonstrate similar rates of success and complications compared to parenteral antibiotics for bone and joint infections: a systematic review and meta-analysis Schreiner G, Fucaloro S, Meija J, Krivicich L, Salzler M. 2025 Oct USA | Six RCTs (1,310 patients with bone and joint infections) | Systemic review and meta-analysis | Clinical cure, treatment failure, adverse events | No significant difference for treatment success rates for oral versus parenteral antibiotics (OR 1.09). Six early switch cohort studies demonstrated that oral antibiotics had significantly higher success (OR = 1.70). Meta-data of both RCTs and early switch cohort studies demonstrated no significant difference in complication rates. | Considerable heterogeneity in antibiotic regimens, infection types, and follow-up duration. |
| Early oral versus prolonged intravenous antimicrobial treatment in children with bone and joint infections: a systematic review and meta-analysis Konstantopoulou A, Berikopoulou MM, Tsoliakos I, Dimopoulou K, Dimopoulou D. March 2026 Athens, Greece | Twenty-four studies (7881 children with bone and joint infections) were included. | Systemic review and meta-analysis | Treatment success, complications, recurrence | Early oral antibiotic therapy achieved comparable clinical outcomes with no increase in treatment failure or complications (RR =0.82). Subgroup analysis across infection types showed consistent treatment effects. | Pediatric-only population limits generalizability to adults; variability among included studies. |
Author Commentary:
Most evidence comes from adults with bone and joint infections (including septic arthritis) treated after surgical or inpatient evaluation, not specifically ED-only cohorts. Still, it gives useful guidance on treatment success and complications. Across adult bone and joint infections (including septic arthritis), appropriately chosen oral regimens appear non-inferior to IV regimens in terms of treatment success, with fewer catheter-related complications and shorter stays. For an adult presenting to the ED with acute joint infection, these data support early transition to, or primary use of, high-bioavailability oral antibiotics in carefully selected, clinically stable patients with susceptible organisms and reliable follow-up, but direct ED-only evidence is limited.
Bottom Line:
In appropriately selected emergency department patients with septic arthritis who have undergone adequate source control and are clinically improving, oral antibiotics appear to be non-inferior to prolonged intravenous antibiotics with respect to treatment success while reducing catheter-related complications.
Level of Evidence:
Level 1: Recent well-done systematic review was considered or a study of high quality is available
References:
- Lima JPC, Chagas KA, Oliveira LBP, Filho BSB, Vital FMR.. Oral versus intravenous antibiotics for bone and joint infections: Systematic review and meta-analysis of randomized controlled trials.
- Schreiner G, Fucaloro S, Meija J, Krivicich L, Salzler M.. Oral antibiotics demonstrate similar rates of success and complications compared to parenteral antibiotics for bone and joint infections: a systematic review and meta-analysis
- Konstantopoulou A, Berikopoulou MM, Tsoliakos I, Dimopoulou K, Dimopoulou D.. Early oral versus prolonged intravenous antimicrobial treatment in children with bone and joint infections: a systematic review and meta-analysis